Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 741.29

-0.7%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (910)	2/27/2004 7:40:15 PM
From: Miljenko Zuanic	Read Replies (1) of 3559

Sound like Novartis does not want to pay 100% of the pre-PIII cost (going from scratch with new formulation) and found 100% of the PIII/pre-marketing cost (with possibility of the 50% recovery only IF drug generate profit???) for ONLY 50% of the potential profit! I will not do ether, IF I am in NVS. IL-1 Trap is high-risk project. While Schleifer was very poor (terrible) CEO from time REGN went public, I must give him one credit. He is among the best in pulling money out of pharma pocket with nothing more to show than "empty PR"! IF I am REGN employee I would build him "Partizansku Spomenicu". Miljenko PS: As Jim mentioned on BV tread, this news was not unexpected.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next